JP JAZZ PHARMACEUTICALS Trademark

Trademark Overview


On Monday, December 10, 2018, a trademark application was filed for JP JAZZ PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the JP JAZZ PHARMACEUTICALS trademark a serial number of 88223219. The federal status of this trademark filing is REGISTERED as of Tuesday, December 17, 2019. This trademark is owned by Jazz Pharmaceuticals, Inc.. The JP JAZZ PHARMACEUTICALS trademark is filed in the Pharmaceutical Products category with the following description:

House mark for a line of pharmaceuticals for the treatment, management and prevention of cancer, psychiatric diseases and disorders, central nervous system conditions, sleep disorders, narcolepsy, schizophrenia, cataplexy, obstructive sleep apnea, and for use in oncological and hematological diseases and disorders; Pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for use in oncology and hematology; pharmaceutical preparations for the treatment and management of neurological, psychiatric, and sleep conditions, diseases, and disorders; pharmaceutical preparations for the treatment and management of cancer, cataplexy, excessive daytime sleepiness, liver disease, narcolepsy, obstructive sleep apnea, and schizophrenia
jp jazz pharmaceuticals

General Information


Serial Number88223219
Word MarkJP JAZZ PHARMACEUTICALS
Filing DateMonday, December 10, 2018
Status700 - REGISTERED
Status DateTuesday, December 17, 2019
Registration Number5935365
Registration DateTuesday, December 17, 2019
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 1, 2019

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of "JAZZ PHARMACEUTICALS" positioned to the right of a circular logo with a stylized depiction of the letters "JP" which vertically splits the circle.
Pseudo MarkJAZZ PHARMACEUTICALS JAZZ PHARMACEUTICALS
NOT AVAILABLE"PHARMACEUTICALS"
Goods and ServicesHouse mark for a line of pharmaceuticals for the treatment, management and prevention of cancer, psychiatric diseases and disorders, central nervous system conditions, sleep disorders, narcolepsy, schizophrenia, cataplexy, obstructive sleep apnea, and for use in oncological and hematological diseases and disorders; Pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for use in oncology and hematology; pharmaceutical preparations for the treatment and management of neurological, psychiatric, and sleep conditions, diseases, and disorders; pharmaceutical preparations for the treatment and management of cancer, cataplexy, excessive daytime sleepiness, liver disease, narcolepsy, obstructive sleep apnea, and schizophrenia

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 2, 2019
Primary Code005
First Use Anywhere DateWednesday, September 8, 2004
First Use In Commerce DateWednesday, September 8, 2004

Trademark Owner History


Party NameJazz Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPalo Alto, CA 94306

Party NameJazz Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPalo Alto, CA 94304

Party NameJazz Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPalo Alto, CA 94304

Trademark Events


Event DateEvent Description
Thursday, December 13, 2018NEW APPLICATION ENTERED
Wednesday, January 2, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 3, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, March 7, 2019ASSIGNED TO EXAMINER
Thursday, March 14, 2019EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Thursday, March 14, 2019EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Thursday, March 14, 2019NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Friday, March 15, 2019ASSIGNED TO LIE
Friday, March 15, 2019COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
Monday, March 25, 2019TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 25, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Saturday, June 15, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, June 15, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 1, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 1, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 2, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 27, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 11, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 1, 2019PUBLISHED FOR OPPOSITION
Tuesday, October 1, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 17, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, May 26, 2021ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, December 17, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, November 11, 2025TEAS SECTION 8 & 15 RECEIVED
Tuesday, November 11, 2025TEAS SECTION 7 REQUEST RECEIVED
Tuesday, November 11, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 11, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, November 11, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 11, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 11, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED